▶ 調査レポート

世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global Diabetes Mellitus Drugs Market Size, Status and Forecast 2021-2027

Global Diabetes Mellitus Drugs Market Size, Status and Forecast 2021-2027「世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年）」（市場規模、市場予測）調査レポートです。• レポートコード：QYR2104Z1821
• 出版社/出版日：QYResearch / 2021年4月15日
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License（同一法人内共有可）￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査資料では、糖尿病治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・糖尿病治療薬の市場動向
・企業の競争状況、市場シェア
・糖尿病治療薬の種類別市場規模（経口薬、注射薬）
・糖尿病治療薬の用途別市場規模（病院、診療所、その他）
・糖尿病治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・糖尿病治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・糖尿病治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・糖尿病治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・糖尿病治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novo Nordisk、Merck & Co、Boehringer Ingelheim、AstraZeneca、Eli Lilly and Company、Johnson & Johnson、Takeda、Sanofi、Gan & Lee Pharmaceuticals、Bayer、Tonghua Dongbao Pharmaceutical Co、Huadong Medicine）
・結論

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia.High blood sugar is caused by defective secretion of insulin or impaired biological function, or both.Long-term hyperglycemia leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.

Market Analysis and Insights: Global Diabetes Mellitus Drugs Market
The global Diabetes Mellitus Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Mellitus Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Mellitus Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Mellitus Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Mellitus Drugs market.

Global Diabetes Mellitus Drugs Scope and Market Size
Diabetes Mellitus Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Mellitus Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Medicine
Injection Medicine

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Merck & Co
Boehringer Ingelheim
AstraZeneca
Eli Lilly and Company
Johnson & Johnson
Takeda
Sanofi
Gan & Lee Pharmaceuticals
Bayer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Mellitus Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Medicine
1.2.3 Injection Medicine
1.3 Market by Application
1.3.1 Global Diabetes Mellitus Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetes Mellitus Drugs Market Perspective (2016-2027)
2.2 Diabetes Mellitus Drugs Growth Trends by Regions
2.2.1 Diabetes Mellitus Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Mellitus Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Mellitus Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Mellitus Drugs Industry Dynamic
2.3.1 Diabetes Mellitus Drugs Market Trends
2.3.2 Diabetes Mellitus Drugs Market Drivers
2.3.3 Diabetes Mellitus Drugs Market Challenges
2.3.4 Diabetes Mellitus Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetes Mellitus Drugs Players by Revenue
3.1.1 Global Top Diabetes Mellitus Drugs Players by Revenue (2016-2021)
3.1.2 Global Diabetes Mellitus Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Mellitus Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Mellitus Drugs Revenue
3.4 Global Diabetes Mellitus Drugs Market Concentration Ratio
3.4.1 Global Diabetes Mellitus Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Mellitus Drugs Revenue in 2020
3.5 Diabetes Mellitus Drugs Key Players Head office and Area Served
3.6 Key Players Diabetes Mellitus Drugs Product Solution and Service
3.7 Date of Enter into Diabetes Mellitus Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetes Mellitus Drugs Breakdown Data by Type
4.1 Global Diabetes Mellitus Drugs Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Mellitus Drugs Forecasted Market Size by Type (2022-2027)

5 Diabetes Mellitus Drugs Breakdown Data by Application
5.1 Global Diabetes Mellitus Drugs Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Mellitus Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetes Mellitus Drugs Market Size (2016-2027)
6.2 North America Diabetes Mellitus Drugs Market Size by Type
6.2.1 North America Diabetes Mellitus Drugs Market Size by Type (2016-2021)
6.2.2 North America Diabetes Mellitus Drugs Market Size by Type (2022-2027)
6.2.3 North America Diabetes Mellitus Drugs Market Size by Type (2016-2027)
6.3 North America Diabetes Mellitus Drugs Market Size by Application
6.3.1 North America Diabetes Mellitus Drugs Market Size by Application (2016-2021)
6.3.2 North America Diabetes Mellitus Drugs Market Size by Application (2022-2027)
6.3.3 North America Diabetes Mellitus Drugs Market Size by Application (2016-2027)
6.4 North America Diabetes Mellitus Drugs Market Size by Country
6.4.1 North America Diabetes Mellitus Drugs Market Size by Country (2016-2021)
6.4.2 North America Diabetes Mellitus Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetes Mellitus Drugs Market Size (2016-2027)
7.2 Europe Diabetes Mellitus Drugs Market Size by Type
7.2.1 Europe Diabetes Mellitus Drugs Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Mellitus Drugs Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Mellitus Drugs Market Size by Type (2016-2027)
7.3 Europe Diabetes Mellitus Drugs Market Size by Application
7.3.1 Europe Diabetes Mellitus Drugs Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Mellitus Drugs Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Mellitus Drugs Market Size by Application (2016-2027)
7.4 Europe Diabetes Mellitus Drugs Market Size by Country
7.4.1 Europe Diabetes Mellitus Drugs Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Mellitus Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetes Mellitus Drugs Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Mellitus Drugs Market Size by Type
8.2.1 Asia-Pacific Diabetes Mellitus Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Mellitus Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Mellitus Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Mellitus Drugs Market Size by Application
8.3.1 Asia-Pacific Diabetes Mellitus Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Mellitus Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Mellitus Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Mellitus Drugs Market Size by Region
8.4.1 Asia-Pacific Diabetes Mellitus Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Mellitus Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetes Mellitus Drugs Market Size (2016-2027)
9.2 Latin America Diabetes Mellitus Drugs Market Size by Type
9.2.1 Latin America Diabetes Mellitus Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Mellitus Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Mellitus Drugs Market Size by Type (2016-2027)
9.3 Latin America Diabetes Mellitus Drugs Market Size by Application
9.3.1 Latin America Diabetes Mellitus Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Mellitus Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Mellitus Drugs Market Size by Application (2016-2027)
9.4 Latin America Diabetes Mellitus Drugs Market Size by Country
9.4.1 Latin America Diabetes Mellitus Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Mellitus Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetes Mellitus Drugs Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Mellitus Drugs Market Size by Type
10.2.1 Middle East & Africa Diabetes Mellitus Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Mellitus Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Mellitus Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Mellitus Drugs Market Size by Application
10.3.1 Middle East & Africa Diabetes Mellitus Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Mellitus Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Mellitus Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Mellitus Drugs Market Size by Country
10.4.1 Middle East & Africa Diabetes Mellitus Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Mellitus Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Mellitus Drugs Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Details
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Diabetes Mellitus Drugs Introduction
11.2.4 Merck & Co Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.2.5 Merck & Co Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Diabetes Mellitus Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Diabetes Mellitus Drugs Introduction
11.4.4 AstraZeneca Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Diabetes Mellitus Drugs Introduction
11.5.4 Eli Lilly and Company Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Diabetes Mellitus Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda
11.7.1 Takeda Company Details
11.7.2 Takeda Business Overview
11.7.3 Takeda Diabetes Mellitus Drugs Introduction
11.7.4 Takeda Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.7.5 Takeda Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Diabetes Mellitus Drugs Introduction
11.8.4 Sanofi Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Gan & Lee Pharmaceuticals
11.9.1 Gan & Lee Pharmaceuticals Company Details
11.9.2 Gan & Lee Pharmaceuticals Business Overview
11.9.3 Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Introduction
11.9.4 Gan & Lee Pharmaceuticals Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.9.5 Gan & Lee Pharmaceuticals Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Bayer Business Overview
11.10.3 Bayer Diabetes Mellitus Drugs Introduction
11.10.4 Bayer Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.10.5 Bayer Recent Development
11.11 Tonghua Dongbao Pharmaceutical Co
11.11.1 Tonghua Dongbao Pharmaceutical Co Company Details
11.11.2 Tonghua Dongbao Pharmaceutical Co Business Overview
11.11.3 Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Introduction
11.11.4 Tonghua Dongbao Pharmaceutical Co Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.11.5 Tonghua Dongbao Pharmaceutical Co Recent Development
11.12 Huadong Medicine
11.12.1 Huadong Medicine Company Details
11.12.2 Huadong Medicine Business Overview
11.12.3 Huadong Medicine Diabetes Mellitus Drugs Introduction
11.12.4 Huadong Medicine Revenue in Diabetes Mellitus Drugs Business (2016-2021)
11.12.5 Huadong Medicine Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetes Mellitus Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Medicine
Table 3. Key Players of Injection Medicine
Table 4. Global Diabetes Mellitus Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Diabetes Mellitus Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetes Mellitus Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Diabetes Mellitus Drugs Market Share by Regions (2016-2021)
Table 8. Global Diabetes Mellitus Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Diabetes Mellitus Drugs Market Share by Regions (2022-2027)
Table 10. Diabetes Mellitus Drugs Market Trends
Table 11. Diabetes Mellitus Drugs Market Drivers
Table 12. Diabetes Mellitus Drugs Market Challenges
Table 13. Diabetes Mellitus Drugs Market Restraints
Table 14. Global Diabetes Mellitus Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Diabetes Mellitus Drugs Market Share by Players (2016-2021)
Table 16. Global Top Diabetes Mellitus Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Mellitus Drugs as of 2020)
Table 17. Ranking of Global Top Diabetes Mellitus Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Diabetes Mellitus Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetes Mellitus Drugs Product Solution and Service
Table 21. Date of Enter into Diabetes Mellitus Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Diabetes Mellitus Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Diabetes Mellitus Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Diabetes Mellitus Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Diabetes Mellitus Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Diabetes Mellitus Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Diabetes Mellitus Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Diabetes Mellitus Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Diabetes Mellitus Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Diabetes Mellitus Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Diabetes Mellitus Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Diabetes Mellitus Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Diabetes Mellitus Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Diabetes Mellitus Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Diabetes Mellitus Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Diabetes Mellitus Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Diabetes Mellitus Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetes Mellitus Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetes Mellitus Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetes Mellitus Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Diabetes Mellitus Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Diabetes Mellitus Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Diabetes Mellitus Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Diabetes Mellitus Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Diabetes Mellitus Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Diabetes Mellitus Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Diabetes Mellitus Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Diabetes Mellitus Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetes Mellitus Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetes Mellitus Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetes Mellitus Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Diabetes Mellitus Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novo Nordisk Company Details
Table 62. Novo Nordisk Business Overview
Table 63. Novo Nordisk Diabetes Mellitus Drugs Product
Table 64. Novo Nordisk Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 65. Novo Nordisk Recent Development
Table 66. Merck & Co Company Details
Table 67. Merck & Co Business Overview
Table 68. Merck & Co Diabetes Mellitus Drugs Product
Table 69. Merck & Co Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 70. Merck & Co Recent Development
Table 71. Boehringer Ingelheim Company Details
Table 72. Boehringer Ingelheim Business Overview
Table 73. Boehringer Ingelheim Diabetes Mellitus Drugs Product
Table 74. Boehringer Ingelheim Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Diabetes Mellitus Drugs Product
Table 79. AstraZeneca Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Eli Lilly and Company Company Details
Table 82. Eli Lilly and Company Business Overview
Table 83. Eli Lilly and Company Diabetes Mellitus Drugs Product
Table 84. Eli Lilly and Company Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 85. Eli Lilly and Company Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Diabetes Mellitus Drugs Product
Table 89. Johnson & Johnson Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Takeda Company Details
Table 92. Takeda Business Overview
Table 93. Takeda Diabetes Mellitus Drugs Product
Table 94. Takeda Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Gan & Lee Pharmaceuticals Company Details
Table 101. Gan & Lee Pharmaceuticals Business Overview
Table 102. Gan & Lee Pharmaceuticals Diabetes Mellitus Drugs Product
Table 103. Gan & Lee Pharmaceuticals Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 104. Gan & Lee Pharmaceuticals Recent Development
Table 105. Bayer Company Details
Table 106. Bayer Business Overview
Table 107. Bayer Diabetes Mellitus Drugs Product
Table 108. Bayer Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 109. Bayer Recent Development
Table 110. Tonghua Dongbao Pharmaceutical Co Company Details
Table 111. Tonghua Dongbao Pharmaceutical Co Business Overview
Table 112. Tonghua Dongbao Pharmaceutical Co Diabetes Mellitus Drugs Product
Table 113. Tonghua Dongbao Pharmaceutical Co Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 114. Tonghua Dongbao Pharmaceutical Co Recent Development
Table 115. Huadong Medicine Company Details
Table 116. Huadong Medicine Business Overview
Table 117. Huadong Medicine Diabetes Mellitus Drugs Product
Table 118. Huadong Medicine Revenue in Diabetes Mellitus Drugs Business (2016-2021) & (US$ Million)
Table 119. Huadong Medicine Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Mellitus Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Medicine Features
Figure 3. Injection Medicine Features
Figure 4. Global Diabetes Mellitus Drugs Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Diabetes Mellitus Drugs Report Years Considered
Figure 9. Global Diabetes Mellitus Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetes Mellitus Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetes Mellitus Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetes Mellitus Drugs Market Share by Regions (2022-2027)
Figure 13. Global Diabetes Mellitus Drugs Market Share by Players in 2020
Figure 14. Global Top Diabetes Mellitus Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Mellitus Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Mellitus Drugs Revenue in 2020
Figure 16. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetes Mellitus Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetes Mellitus Drugs Market Share by Type (2016-2027)
Figure 20. North America Diabetes Mellitus Drugs Market Share by Application (2016-2027)
Figure 21. North America Diabetes Mellitus Drugs Market Share by Country (2016-2027)
Figure 22. United States Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetes Mellitus Drugs Market Share by Type (2016-2027)
Figure 26. Europe Diabetes Mellitus Drugs Market Share by Application (2016-2027)
Figure 27. Europe Diabetes Mellitus Drugs Market Share by Country (2016-2027)
Figure 28. Germany Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetes Mellitus Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetes Mellitus Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Diabetes Mellitus Drugs Market Share by Region (2016-2027)
Figure 38. China Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetes Mellitus Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Diabetes Mellitus Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Diabetes Mellitus Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetes Mellitus Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetes Mellitus Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Diabetes Mellitus Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetes Mellitus Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novo Nordisk Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 58. Merck & Co Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 59. Boehringer Ingelheim Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 61. Eli Lilly and Company Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 65. Gan & Lee Pharmaceuticals Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 67. Tonghua Dongbao Pharmaceutical Co Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 68. Huadong Medicine Revenue Growth Rate in Diabetes Mellitus Drugs Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

関連レポート
  • 世界のサフランビール市場インサイト・予測（～2027年）
    Global Saffron Beer Market Insights and Forecast to 2027
    QY2112C02136 2021年12月15日 106Pages
    本調査資料はサフランビールの世界市場の現状について調査・分析し、2027年までの市場を予測しました。サフランビールの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（オーガニック、従来型）、用途別市場規模（飲料産業、醸造産業、健康・ウェルネス産業、パーソナルケア産業、その他）、主要地域...
  • 世界のコノテガシワ抽出物市場 2028年：錠剤、粉末、カプセル、その他
    Global Cacumen Platycladi Extract Market Insights, Forecast to 2028
    QY2207C0696 2022年7月15日 93Pages
    新型コロナウイルス感染症のパンデミックにより、世界のコノテガシワ抽出物の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にコノテガシワ抽出物...
  • 世界のハイブリッド電気自動車（HEV）用電気めっき試薬市場 2028年：酸めっき試薬、アルカリめっき試薬
    Global Electroplating Reagents for Hybrid Electric Vehicles (HEVs) Market Insights, Forecast to 2028
    QY2207C0258 2022年7月15日 94Pages
    新型コロナウイルス感染症のパンデミックにより、世界のハイブリッド電気自動車（HEV）用電気めっき試薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、...
  • 世界のシチコリンナトリウム市場 2028年：純度≥98％、純度≥99％
    Global Citicoline Sodium Market Insights, Forecast to 2028
    QY2207C0849 2022年7月8日 94Pages
    新型コロナウイルス感染症のパンデミックにより、世界のシチコリンナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシチコリンナトリ...
  • ポリブチレンサクシネート(PBS)のグローバル市場インサイト・予測（～2028年）
    Global Poly Butylene Succinate(PBS) Market Insights and Forecast to 2028
    QY2203B06288 2022年3月18日 112Pages
    新型コロナウイルス感染症のパンデミックにより、世界のポリブチレンサクシネート(PBS)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にポ...
  • キーボード保護材（キーボードスキン）のグローバル市場インサイト・予測（～2028年）
    Global Keyboard Protector(Keyboard Skin) Market Insights and Forecast to 2028
    QY2203B02423 2022年3月18日 110Pages
    新型コロナウイルス感染症のパンデミックにより、世界のキーボード保護材（キーボードスキン）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...
  • リアクティブオレンジ35のグローバル市場インサイト・予測（～2028年）
    Global Reactive Orange 35 Market Insights, Forecast to 2028
    QY2203B06937 2022年3月18日 95Pages
    新型コロナウイルス感染症のパンデミックにより、世界のリアクティブオレンジ35の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリアクティブ...
  • 世界のシュウ酸ネオジム市場インサイト・予測（～2027年）
    Global Neodymium Oxalate Market Insights and Forecast to 2027
    QY2112C00583 2021年12月15日 98Pages
    本調査資料はシュウ酸ネオジムの世界市場の現状について調査・分析し、2027年までの市場を予測しました。シュウ酸ネオジムの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（純度99％、純度99.9％、純度99.99％、純度99.999％）、用途別市場規模（マグネット製造、ガラス製造、その...
  • 世界のリングスピンドル市場インサイト・予測（～2027年）
    Global Ring Spindle Market Insights and Forecast to 2027
    QY2112C03137 2021年12月15日 96Pages
    本調査資料はリングスピンドルの世界市場の現状について調査・分析し、2027年までの市場を予測しました。リングスピンドルの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（手動ドッフィング用スピンドル、自動ドッフィング用スピンドル、その他）、用途別市場規模（紡績業、その他）、主要地域別市...
  • 世界のカーボンファイバーフェルト市場 2028年：ポリアクリロニトリルベース炭素繊維フェルト、粘性ベース炭素繊維フェルト、アスファルトベース炭素繊維フェルト
    Global Carbon Fiber Felt Market Insights, Forecast to 2028
    QY2207C0729 2022年7月15日 115Pages
    新型コロナウイルス感染症のパンデミックにより、世界のカーボンファイバーフェルトの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカーボンフ...